Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 | Nature Genetics
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70

Abstract

At least eight inherited human neurodegenerative diseases are caused by expansion of a polyglutamine domain within the respective proteins1,2. This confers dominant toxicity on the proteins, leading to dysfunction and loss of neurons. Expanded polyglutamine proteins form aggregates, including nuclear inclusions (NI), within neurons, possibly due to misfolding of the proteins3,4,5. NI are ubiquitinated and sequester molecular chaperone proteins and proteasome components6,7,8,9, suggesting that disease pathogenesis includes activation of cellular stress pathways to help refold, disaggregate or degrade the mutant disease proteins. Overexpression of specific chaperone proteins reduces polyglutamine aggregation in transfected cells7,8,9, but whether this alters toxicity is unknown. Using a Drosophila melanogaster model of polyglutamine disease10, we show that directed expression of the molecular chaperone HSP70 suppresses polyglutamine-induced neurodegeneration in vivo. Suppression by HSP70 occurred without a visible effect on NI formation, indicating that polyglutamine toxicity can be dissociated from formation of large aggregates. Our studies indicate that HSP70 or related molecular chaperones may provide a means of treating these and other neurodegenerative diseases associated with abnormal protein conformation and toxicity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Drosophila HSP70 localizes to nuclear inclusions.
Figure 2: HSP70 suppresses polyglutamine-induced neurodegeneration in vivo.
Figure 3: HSP70 slows progressive degeneration of the nervous system.
Figure 4: NI formation in flies expressing polyglutamine protein and HSPA1L.
Figure 5: A dominant-negative form of a constitutively expressed cytoplasmic fly HSP70 enhances polyglutamine disease.

Similar content being viewed by others

References

  1. Paulson, H. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. Am. J. Hum. Genet. 64, 339–345 (1999).

    Article  CAS  Google Scholar 

  2. Perutz, M. Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci. 24, 58–63 (1999).

    Article  CAS  Google Scholar 

  3. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 (1997).

    Article  CAS  Google Scholar 

  4. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).

    Article  CAS  Google Scholar 

  5. Paulson, H.L. et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 19, 333–344 (1997).

    Article  CAS  Google Scholar 

  6. Chai, Y., Koppenmhafer, S., Shoesmith, S., Perez, M. & Paulson, H. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8, 673–682 (1998).

    Article  Google Scholar 

  7. Cummings, C.J. et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19, 148–154 (1998).

    Article  CAS  Google Scholar 

  8. Stenoien, D. et al. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet. 8, 731–741 (1999).

    Article  CAS  Google Scholar 

  9. Chai, Y., Koppenhafer, S., Bonini, N. & Paulson, H. Analysis of the role of heat shock protein (Hsp) chaperones in polyglutamine disease. J. Neurosci. (in press).

  10. Warrick, J.M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939–949 (1998).

    Article  CAS  Google Scholar 

  11. Ranum, L. et al. Spinocerebellar ataxia type 1 and Machado-Joseph disease: incidence of CAG expansions among adult-onset ataxia patients from 311 families with dominant, recessive, or sporadic ataxia. Am. J. Hum. Genet. 57, 603–603 (1995).

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Schols, L. et al. Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in German SCA patients. Hum. Mol. Genet. 4, 1001–1005 (1995).

    Article  CAS  Google Scholar 

  13. Durr, A. et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathologic features. Ann. Neurol. 39, 490–491 (1996).

    Article  CAS  Google Scholar 

  14. Ikeda, H. et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nature Genet. 13, 196–202 (1996).

    Article  CAS  Google Scholar 

  15. Brand, A.H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415 (1993).

    CAS  Google Scholar 

  16. Wolff, T. & Ready, D.F. in The Development of Drosophila melanogaster (eds Bate, M. & Martinez-Arias, A.) 1277–1325 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1993).

  17. Hartl, F. Molecular chaperones in cellular protein folding. Nature 381, 571–580 (1996).

    Article  CAS  Google Scholar 

  18. Hunt, C. & Morimoto, R. Conserved features of eukaryotic hsp70 genes revealed by comparison with the nucleotide sequence of human hsp70. Proc. Natl Acad. Sci. USA 82, 6455–6459 (1985).

    Article  CAS  Google Scholar 

  19. Lin, D.M. & Goodman, C.S. Ectopic and increased expression of fasciclin II alters motoneuron growth cone guidance. Neuron 13, 507–523 (1994).

    Article  CAS  Google Scholar 

  20. Klement, I. et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-mediated disease in SCA1 transgenic mice. Cell 95, 41–53 (1998).

    Article  CAS  Google Scholar 

  21. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55–66 (1998).

    Article  CAS  Google Scholar 

  22. Elefant, F. & Palter, K. Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality. Mol. Biol. Cell 10, 2101–2117 (1999).

    Article  CAS  Google Scholar 

  23. DebBurman, S., Raymond, G., Caughey, B. & Lindquist, S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl Acad. Sci. USA 94, 13938–13943 (1997).

    Article  CAS  Google Scholar 

  24. Glover, J. & Lindquist, S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94, 73–82 (1998).

    Article  CAS  Google Scholar 

  25. Jackson, G. et al. Polyglutamine-expanded human Huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633–642 (1998).

    Article  CAS  Google Scholar 

  26. Landsbury, P. Jr Structural neurobiology: are seeds at the root of neuronal degeneration? Neuron 19, 1151–1154 (1997).

    Article  Google Scholar 

  27. Prusiner, S. Prion diseases and the BSE crisis. Science 278, 245–251 (1997).

    Article  CAS  Google Scholar 

  28. Selkoe, D. Alzheimer's disease: genotypes, phenotypes, and treatments. Science 275, 630–631 (1997).

    Article  CAS  Google Scholar 

  29. Polymeropoulos, M. et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045–2047 (1997).

    Article  CAS  Google Scholar 

  30. Rubin, G.M. & Spradling, A.C. Genetic transformation of Drosophila with transposable element vectors. Science 218, 348–353 (1982).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank A. Cashmore and L. Lillien for critical reading of the manuscript. This research was funded in part by grants from the R.J. Carver Charitable Trust, faculty start-up funding from the University of Iowa Howard Hughes Medical Institute Resources Program (H.L.P.), the Wills Foundation (J.M.W.), the Wellcome Trust (H.Y.E.C.), the HDSA Coalition for the Cure, Hereditary Disease Foundation, Alzheimer's Foundation and the David and Lucile Packard Foundation (N.M.B.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nancy M. Bonini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Warrick, J., Chan, H., Gray-Board, G. et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 23, 425–428 (1999). https://doi.org/10.1038/70532

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/70532

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing